We curate a digest of the latest news in our field for advocates, policymakers, community coalitions and all who work toward shaping policies and practices to effectively prevent substance use and treat addiction.
Researchers who accept money from the tobacco industry will no longer be able to get their work published in PLoS Medicine, a journal produced by the Public Library of Science (PLoS).
A bill that would cut sentences for drug offenses and put more money into addiction treatment programs has support from both sides of the aisle in the Colorado statehouse.
Niche tobacco company Star Scientific is seeking the U.S. Food and Drug Administration's (FDA) approval to sell its wintergreen-flavored, dissolvable tobacco lozenges as 'modified risk' products.
Youths who call for help when underage drinkers get sick from drinking will get leniency -- but not a free pass -- from the courts under legislation approved by a Utah Senate panel.
The rate of alcohol-related fatal car crashes has risen among some populations of female drivers, a worrying trend that runs counter to the decline in such crashes among young men.
The packaging is almost exactly the same, but Philip Morris' Marlboro Lights brand is no more: with terms like "light" and "mild" now banned by law from tobacco marketing, the cigarettes are now being called "Marlboro Gold."
Individuals seeking public assistance or seeking to serve the public would be required to submit to drug tests under a measure approved by the Missouri House of Representatives.
Patients receiving or considering methadone maintenance treatment (MMT) for opioid dependence often express concern that methadone causes bone disease and dental decay.
Researchers performed a systematic review of controlled trials to determine whether brief intervention (BI) improves outcomes for addressing heavy alcohol use in general hospital patients.
This randomized controlled trial tested whether a brief intervention (BI) involving two sessions of motivational interviewing could reduce problematic prescription drug (PD) misuse among inpatients at a university hospital.
Opioid agonist treatment (OAT) with methadone or buprenorphine is effective for reducing illicit drug use among opioid-dependent patients, but the diversion of these agents may be harmful.
A new proposal to amend a landmark federal privacy law is butting up against resistance from recovery advocates and others, as the addiction treatment and recovery community struggles to strike a balance between the need for integration with mainstream medicine and privacy concerns about the use of electronic medical records.
This website uses cookies. We use cookies and similar technologies to give
you the best experience. By using this website, you accept our Privacy Policy and Terms of Use.
Get Support
